Healthcare Industry Insights

Tuesday, 1 November 2016

Portable X-Ray and CT Scan Devices Market Share, Size, Industry Trends and Forecasts to 2020 | Hexa Research

According to a new study by Hexa Research, the global market for portable X-ray and CT scan devices will grow at a CAGR of 7.5% from 2013 to 2020. The demand will be driven by growing cases of accidents and health conditions necessitating orthopedic, cardiovascular or brain-related investigation. New product developments in portable medical devices market are being facilitated by technological advancements like wireless devices and capital deployment in healthcare. Additionally, growing preference for diagnostic techniques that are minimally invasive and can be brought to the patients’ doorstep is proving beneficial to growth. The elderly are prone to falls and suffer from orthopedic issues. Growing worldwide aging population is leading to a rise in implant procedures. This makes portable screening devices important.

Hexa Research observes that North America generated the most regional demand for portable X-ray and CT scan devices. Its dominance is likely to continue owing to surge in aging populace and technological superiority. Emerging economies in Asia and Latin America will augment future demand for portable X-ray and CT scan devices. These developing markets are characterized by a growth in technologically advanced and affordable products. Asia Pacific market is anticipated to grow at a CAGR of more than 10% from 2013 to 2020.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

X-ray devices accounted for a larger market share as compared to CT scan devices. For the period from 2015 to 2020, demand for X-ray devices is likely to fall while that of CT scan devices will witness substantial growth.

Hexa Research found that on the basis of technology, medium slice scanners, with benefits like cost effectiveness and high performance, accounted for more than 59% of the CT scan market segment. In X-ray devices segment, computed radiography was the preferred technology due to its affordability and user friendliness. In the near future, digital radiography-based portable X-ray machines are foreseen to witness highest growth. They offer features like fastest image acquisition rate, high throughput rate, low radiation and high quality imaging. Key operators in the global portable X-ray and CT scan devices industry are GE Healthcare, Philips Healthcare, Hitachi Medical System, Varian Medical System, Siemens Healthcare, etc. Philips Healthcare with a market share of more than 16.5% assumed the leadership position in 2012.

Browse Full Report @ http://www.hexaresearch.com/research-report/portable-x-ray-and-ct-scan-devices-industry/

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Wednesday, 19 October 2016

Audiology Devices Market Size, Analysis, Growth, Trends and Forecasts to 2024 | Hexa Research

Audiology devices are known to facilitate in treatment of hearing disorders such as congenital hearing and nerve deafness. It caters to three types of hearing loss viz., conductive, sensorineural, and mixed and grouped according to severity of deafness.

The global audiology devices market is estimated to grow at a 4.9% CAGR over the forecast phase (2016-2024). It would be worth around USD 10 billion by 2024. Technological advances of these devices as well as the increasing need by the elderly as well as those afflicted with hearing disorders will drive the market.

The market is segmented by products and regions. Products of the audiology devices market encompass of diagnostic devices, cochlear implants, hearing aid, technological aid, and bone anchoring hearing aids (BAHA). Hearing aids are further divided into In-the-ear (ITE), Receiver-in-the-ear (RITE), canal hearing, and Behind-the-ear (BTE) aids. Canal hearing aids encompass completely-in-canal (CIC), in-the-canal (ITC) hearing, and invisible-in-canal aids. Major end-users of audiology devices are audiologists, service providers, and the healthcare sector.

Browse Full Report with TOC @ https://www.hexaresearch.com/research-report/audiology-devices-industry

Hearing aids was the leading product of the market in 2015. It generated more than 60% revenue on account of its user-friendliness and high comfort. BTE aids had the largest share (55%) of the market in 2015. Cochlear implants are predicted to see major growth due to its effectiveness. Demand for canal hearing aids is projected to drive market demand in the coming years.

Asia Pacific, Europe, North America, and RoW (Rest of the World) comprise as major geographical regions of the market. North America dominated the audiology devices market in 2015 owing to superior healthcare infrastructure and high disposable incomes. Europe accounted over 40% revenue shares in the same year. Asia Pacific is predicted to display a CAGR above 7% over the forecast period. Largely untapped markets in India and China will aid in market growth.

Reputed global vendors of the audiology devices market are NHC/Amplifon, Duracell, Sophono (Medtronic), and Starkey Hearing Technologies. They employ strategies of mergers, acquisitions, alliances and partnerships in order to stay competitive. Main challenges faced by these players are lowered prices and increased shelf life of these products. A clear policy regarding fair trade practices can create new pathways.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-devices-industry

About Us:

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Monday, 3 October 2016

Neurostimulation Devices Market Analysis and Forecasts, 2012 to 2020 | Hexa Research

A recent study by Hexa Research revealed that limited range of treatment choices relating to medical conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key drivers of the global neurostimulation devices market. An upcoming application area is the use of neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. The neurostimulation devices market is benefitting from technological advancements like the transdermal neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by Medtronics, Inc. Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also driving market growth. Accelerated demand for neurostimulation devices in the future years is expected to result from untapped market opportunities in emerging economies of Asia as well as Latin America and the growing number of externally funded clinical programs for development of new products.

Browse Full Report @ https://www.hexaresearch.com/research-report/neurostimulation-devices-industry/

Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key product segments in the neurostimulation devices market. Spinal cord stimulation devices, with a contribution of more than half to the total revenues, were the dominant product segment in 2012.

Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed more than 65% to the total demand that year. This was chiefly due to high incidence of conditions characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices.

While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the fastest in future. Fast-developing economies like India and China will result in the Asia Pacific neurostimulation devices market growing at CAGR higher than 16% from 2013 to 2020.

Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability. Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., and St. Jude Medical.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Thursday, 29 September 2016

Dyslipidemia Therapeutics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 | Hexa Research

Dyslipidemia is an interminable metabolic disorder, described by improper level of low thickness lipoprotein, high thickness lipoprotein, and triglycerides. The expanding demand and solutions of these medicines is offering lucrative growth opportunities for the dyslipidemia market. The current dyslipidemia business sector is overwhelmed by the statins, the progressive medications that diminish low-thickness lipoprotein cholesterol (LDL-C) and that have been demonstrated to lessen the danger of cardiovascular occasions, for example, heart assault and stroke. The launch of the proprotein convertase subtilisin/kexin type 9 (PCSK9) biologics and the cholesteryl ester transfer protein (CETP) inhibitors is anticipated to boost the industry growth. Nonetheless, loss of patent restrictiveness of particles, for example, crestor, zetia, and vytorin is required to hamper the development of the business sector amid the gauge time frame

The launch of PCSK9 inhibitors and human monoclobal antibody biologics to treat high LDL-C statins are expected to drive the industry demand.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/dyslipidemia-therapeutics-market

PCSK9 Inhibitors is normally less utilized because of their potential for medication cooperation’s and poor patient resistance for side effects. The dispatch of the PCSK9s inhibitors might be approved by the U.S. food and Drug Administration (FDA) for use in the treatment of dyslipidemia. The PCSK9 inhibitors are sorts of prescriptions called monoclonal antibodies, which impersonate the body's own particular safe framework by joining to particular focuses on cells to create the desired result. While monoclonal antibodies are used to treat tumor, immune system illnesses and other conditions, they are widely used for the treatment of dyslipidemia.

High cholesterol, especially known as LDL-C, is the most widely recognized type of dyslipidemia. In information from the clinical system to date, Repatha has exhibited reliable, huge and solid diminishment in LDL-C levels with ideal consequences for other lipid parameters in around 6,000 patients with essential hyperlipidemia and blended dyslipidemia. Repatha, being produced by Amgen researchers, is intended to tie to PCSK9 and inhibit PCSK9 from official to LDL receptors on the liver surface. When PCSK9 are not there, there are more LDL receptors on the surface of the liver to expel LDL-C from the blood

The dyslipidemia drugs market can be segmented into bile acid resins, niacins, fibric acid derivatives, statins, and others (cholesterol absorption inhibitors and combination drugs).

The statins section involves consolidated market revenue of statin drugs, for example, atorvastatin, fluvastatin, rosuvastatin, pravastatin, simvastatin, pitavastatin, and lovastatin. The bile acids segment included resins, for example, Cholestyramine, Colestipol, Colesevelam, and Cholybar. The fibric corrosive, and omega-3 unsaturated fat subsidiaries portion involves nonexclusive medications, for example, Fenofibrate, Clofibrate, and Bezafibrate. Other marked omega-3 unsaturated fats incorporate Lovaza, Vascespa, and Omtryg. Niacins incorporates medications, for example, Niaspan, Slo-Niacin, and Niacor. The others divisions includes market examination of drug therapy treatments, for example, Advicor, Vytorin, and Caduet, and in addition cholesterol inhibitor drugs.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/pharmaceuticals-industry

Expanding frequencies of dyslipidemia in developed countries such as North America and Europe and in developing countries such as Asia Pacific and Latin America regions combined with rising number of solution for medications, for example, statins and fibric corrosive subordinates drives the dyslipidemia drugs market development. In 2014, North America ruled the worldwide dyslipidemia drugs market. Europe represented the second biggest offer i.e. around 25% of the aggregate business sector in 2014 inferable from the ideal development conditions for pharmaceutical producers because of moderateness for marked details by purchasers. As indicated by the Centers for Disease Control and Prevention, cholesterol variations are quickly expanding in countries like North America and Europe. Positive government endorsement strategies combined with predictable rateof dyslipidemia in these regions drives the development of dyslipidemia medications market in North America.

Some of the prominent players in the global dyslipidemia drugs market are Pfizer Inc., Novartis AG,Pfizer Inc.,Merck & Co., Inc.,Pfizer Inc., Inc., Abbott Laboratories,Amgen, Teva Pharmaceutical Industries Ltd.,Pfizer Inc., Bristol Myers Squibb Company., GlaxoSmithKline Takeda Pharmaceutical Company Limitedand others.

Browse Our Upcoming Market Reports @ https://www.hexaresearch.com/upcoming-reports

About Us:

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Wednesday, 28 September 2016

Electromedical and X-ray Equipment Market Analysis, Growth, Trends and Forecasts, 2016 to 2024 | Hexa Research

X-beam is a kind of electromagnetic ionizing radiation with applications in a broadened scope of businesses. In therapeutic industry, X-beam gadgets constitute the biggest offer of the symptomatic imaging market. The maturing of the world's population and the rising occurrence of growth, coronary illness, and different conditions is driving the demand for electromedical and X-ray equipment market for cancer, heart disease, and X-rat gadgets. Interest is driven by mechanical progressions, demographics (the maturing US populace drives the requirement for medicinal items), and the necessities of the human services industry. The profitability of individual organizations relies on upon operations and viable advertising. Vast organizations appreciate economies of scale in examination, assembling, advertising, and conveyance. Littler organizations can contend adequately by creating inventive advancements or claim to fame items for corner markets, for example, growth treatment device.

Accessibility of substantial number of players in the business sector has led to a nonstop evolvement of cutting edge advances to build image quality. Advanced imaging procedures keep on evolving with enhancements in picture quality, measurement lessening systems, and efficiencies in work process. The X-ray gadgets innovation has moved from simple imaging to advance. X-rays show numerous applications in the diagnostic as well as therapeutic areas of cancer, cardiovascular and mid-section illnesses to give some examples. Fast advances in radiology that have happened in the previous couple of decades have made ready for the extension of the medicinal imaging hardware market. Imaging gadgets, for example, magnetic resonance imaging (MRI), computed tomography (CT or CAT), and ultrasound have permitted further choices for treatment direction with low dismalness. This has helped doctors to evaluate patients without surgical mediation and along these lines enhance the patient results and personal satisfaction

X-ray imaging gadgets constituted the key fragmenst in the worldwide medical imaging equipment market. The key driving forces for the development of this segment includes expanding occurrence of scatters and simple accessibility and adequacy of x-ray gadgets. Rising occurrence of cardiovascular, respiratory, oral, gastrointestinal, and genitourinary scatters are boosting dependence on a few propelled x-beam indicative gadgets all around. The WHO gauges that around 60% to 90% of school kids and 80% to 90% grown-ups (matured 19 to 34 years) experience the ill effects of dental cavities. In addition, the worldwide rate of oral growth ranges between 1-10 cases for every 100,000 people. These two variables, combined with an expansive patient pool of patients experiencing dental pits, is expected to boost the industry growth. Among the x-ray gadgets market, stationary gadgets overwhelmed the business sector by ideals of being routinely utilized imaging gadgets. These are likewise a more financially savvy choice contrasted with compact x-beam hardware gadgets. Stationary gadgets are for the most part favored in the underserved markets of Asia and Africa.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/medical-imaging-industry

Based on product type, the market is segmented into Digital Radiography (DR), Computed Radiography (CR) and retrofit radiography system. Electro-medical equipment includes a variety of powered devices, such as pacemakers, patient-monitoring systems, MRI machines, diagnostic imaging equipment (including informatics equipment), and ultrasonic scanning devices.

Established markets such as the US, Western Europe, and Japan are top sales regions for the industry. Developing nations such as Brazil, Russia, India, and China are targeted by companies in the industry for growth.

Major US companies include Medtronic,Hologic, Varian Medical Systems,, St Jude Medical and ZollMedical, as well as General Electric. Outside the US, major companies includeSonova (Switzerland), St Jude Medical,, St Jude Medical., Bracco Imaging S.p.A, , Agfa-Gevaert N.V ,Canon, Inc., Fujifilm Holdings Corporation,,Agfa-Gevaert N.V, Hologic, Inc., Hitachi Medical Corporation, Konica Minolta, Inc., Shimadzu Corporation,, Agfa-Gevaert N.V., Philips Healthcare, , Agfa-Gevaert N.V , Thales group,, Agfa-Gevaert N.V, Varian Medical Systems, Inc., , Agfa-Gevaert N.V and Ziehm Imaging, Inc.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/electromedical-x-ray-equipment-market

About Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Tuesday, 27 September 2016

DNA Diagnostics Market Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 | Hexa Research

DNA diagnostics is a technique used to detect and analyze the biological markers in the proteome and genome by applying the theory of microbiology. The utilization of this technique was initialised in early 1990’s. This technique is extensively used for detecting and testing of infectious, genetic and chronic diseases. Early disease detection and prevention becomes easy by the DNA diagnostics in order to increase the efficiency of chronic disease identification.

Some of the key factors that are driving the growth are increasing the prevalence of several types of cancers, myogenic diseases and infectious disease, acceptance or personalised medicines and improving molecular technology. In addition, increasing awareness of DNA diagnosis, continuous development of biomarkers and early stage curing of cancers are propelling growth and is expected to grow significantly over the forecast period. Furthermore, innovation in the proteomics & molecular technology, and reformed reimbursement policy is fuelling the over the past few years. However, the high cost of DNA diagnostics integration, lack of skill to handle complex & new platforms and stringent regulatory framework is restraining the growth. An increasing number of cancer patients, rapid shifting to personalised medicines from traditional diagnostics are key opportunities for players to propel expansion.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/dna-diagnostics-market

DNA diagnostics sector is segregated on the basis of its product into three types such as isolation & purification kits, software & service, instruments, and amplification kits. Owing to growing acceptance of DNA diagnosis, advanced healthcare facilities, competitive cost framework and availability of instruments have dominated the instrument segment. Software & service segment is expected to witness significant growth on account of technological advancement and rising interference of information technology over the forecast period. On the basis of technology, this sector is segmented into five technologies including mass spectrometry, DNA sequencing, PCR, in-situ hybridization, microarray and fingerprinting. Fingerprinting technology is further divided into polymerase chain reaction and fragment length polymorphism. Owing to the ability to separate and isolating property from collected samples PCR technology has the largest share.

The industry is classified on the basis of applications into disease diagnostics, paternity testing, and forensics and organ transplantation. Disease diagnostics had acquired the highest share in 2015 and is expected to grow significantly over the forecast period owing to increasing rate of infectious disease, different types of cancers and myogenic diseases. The industry is segregated into four segments on the basis of end-user applications such as self-testing or OTC, diagnostic laboratories, hospitals, the point of care and research laboratories. The hospital has acquired the maximum share of the market in 2015 on account of increasing use of diagnostics tests for the detection of the disease.

Browse Category Related Market Reports @ https://www.hexaresearch.com/research-category/biotechnology-industry

North America was estimated to account for the highest share in 2015, followed by Europe, Asia Pacific, and rest of the world. Owing to the presence of high technology infrastructure, investments in the development healthcare infrastructure and governments endeavour along with the high prevalence of chronic disease is propelling the growth of the North American sector. Asia Pacific is expected to experience significant growth owing to increasing funding for the healthcare infrastructure, rising population and increase in disposable income of population over the forecast period. In addition, continuous R&D activities in the DNA testing research and government initiative for the prevalence of chronic disease in this region will fuel expansion.

Some of the key market players in this market are Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Gene-Probe Inc., Novartis, Illumina Inc., Cephide, Johnson and Johnson, Sysmex, Bio-rad laboratories, and Bayer Diagnostic. Innovative products are being introduced in the market, as the players are launching new products in the market. Some of the key players are also entering into collaborations, partnerships and agreements with the hospitals & laboratories to strengthen their market position, enhance the market presence and gain a competitive edge over other players.

Widespread use of these techniques in various applications along with the higher incidence rates of chronic disease and increasing awareness of personalised medicines are key trends which will be expected to fuel the growth of DNA diagnostics industry over the forecast period. The major companies such as Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, Gene-Probe Inc., Novartis, Illumina Inc., Cephide, Johnson and Johnson, Sysmex, Bio-rad laboratories, and Bayer Diagnostic are expected to dominate the market over the forecast period owing to their continuous efforts intended to design and emphasize on new product developments to accommodate the consumer demand. This industry is expected to become highly competitive over the forecast period owing to the fact that it is driven by incorporation of new technologies and development of cost-effective products.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/dna-diagnostics-market

About Us:

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Tuesday, 20 September 2016

Optical Coherence Tomography (OCT) Market Share, Size, Analysis, Growth, Industry Trends and Forecasts, 2013 to 2019| Hexa Research

Optical coherence tomography market is a non-invasive medical procedure applied to image various components of biological tissues like structural information, polarization sensitivity and blood flow. It does not require physical contact with the patient and is a safe and effective diagnostic technique.

According to a recent study conducted by Hexa Research the usage of this technology is distinct from other imaging techniques like magnetic resonance imaging and ultrasound imaging. Growing preference for non-invasive medical procedures and widespread global prevalence of ophthalmic diseases are the key demand drivers for optical coherence tomography market. Growing cases of skin and neurological disorders and rising awareness levels are also important contributors to growth. WHO estimates that the share of geriatrics which was 13% of the total global population in 2010 will rise to 53% 2020. Rising number of geriatrics will also propel demand for the global optical coherence tomography market.

Browse Full Report @ https://www.hexaresearch.com/upcoming-research/optical-coherence-tomography-industry

Hexa Research notes that ongoing technological research and resource deployments in new product development are expected to benefit future market growth. Opportunities also exist due to growing penetration of niche technologies like high resolution optical coherence tomography in areas like dermatology and gastroenterology. Furthermore, the market is characterized by high unmet medical needs and a steadily improving healthcare infrastructure, especially in emerging regions like Asia and Latin America.

North American optical coherence tomography industry features higher adoption of advanced imaging modalities and heavy spending from the government. These factors are likely to augment future demand. Therefore, North America is expected to retain market leadership in the coming years. Asia Pacific will experience fastest growth in the forthcoming years, mainly due to immense market potential in emerging countries of the region.

Hexa Research enlists Carl Zeiss, Heliotis AG, Michelson Diagnostics, Agfa Healthcare, etc. as the key market players in the global optical coherence tomography industry. Main application segments are ophthalmology, dermatology, cancer detection, dentistry, intra surgery for tumor margining and gastroenterology. The products can be segmented into time domain and polarization sensitive, full-field and optical delay and fourier-domain and time encoded optical coherence tomography.

Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcare-industry

About Us:

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/